Science Explorer Back to mapMap
Discussion

Eli Lilly (United Kingdom)

In research, Eli Lilly (United Kingdom) stands highest in Health Sciences (#3,412 of 16,688 worldwide), Life Sciences (#2,343 of 11,023 worldwide) and Medicine (#3,273 of 14,558 worldwide), over all time.

World rank, 2022-now
#22,113
of 22,385 · #6,538 all time
Rank in United Kingdom
#848
of 862
Research works
827
▼ 38% vs 2018-21
Citations
26k
31.0 per fractional work
Top-10% rate
10.9%
all institutions 10.0%
vs its own fields
1.00×
1.00× is exactly expected
Open access
36%
world 40%
International
56%
world 18%

What is Eli Lilly (United Kingdom) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
Health SciencesDomain #3,412 of 16,688 11.0%358
Life SciencesDomain #2,343 of 11,023 10.4%270
MedicineField #3,273 of 14,558 10.7%343
Biochemistry, Genetics and Molecular BiologyField #2,345 of 5,801 10.3%123
Physical SciencesDomain #13,443 of 17,446 9.5%133

Each strip is that field's whole ranked pool, with the notch where Eli Lilly (United Kingdom) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).

Which fields of science does Eli Lilly (United Kingdom) work in?

In 2022-now, 64% of research at Eli Lilly (United Kingdom) is in Health Sciences, 23% in Life Sciences. Its largest fields are Medicine (61%), Biochemistry, Genetics and Molecular Biology (12%), Neuroscience (7%). It does 2.5× the world's share of Health Sciences.

Health Sciences: 40 fractional works · 64.2% of its workMedicine: 38 fractional works · 60.7% of its workPsychiatry and Mental health: 6 fractional works · 8.8% of its workEndocrinology, Diabetes and Metabolism: 6 fractional works · 8.7% of its workPhysiology: 5 fractional works · 7.9% of its workPulmonary and Respiratory Medicine: 4 fractional works · 5.8% of its workOncology: 3 fractional works · 4.1% of its workPathology and Forensic Medicine: 2 fractional works · 3.8% of its workRheumatology: 2 fractional works · 3.5% of its workEpidemiology: 2 fractional works · 2.8% of its workSurgery: 2 fractional works · 2.8% of its workPharmacology: 1 fractional works · 1.7% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 1.2% of its workNeurology: 1 fractional works · 1.0% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 0.9% of its workGeriatrics and Gerontology: 1 fractional works · 0.8% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 0.8% of its workGastroenterology: 0 fractional works · 0.7% of its workHepatology: 0 fractional works · 0.7% of its workDermatology: 0 fractional works · 0.6% of its workInfectious Diseases: 0 fractional works · 0.6% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.5% of its workHealth Informatics: 0 fractional works · 0.4% of its workComplementary and alternative medicine: 0 fractional works · 0.4% of its workHematology: 0 fractional works · 0.3% of its workBiochemistry: 0 fractional works · 0.3% of its workGenetics: 0 fractional works · 0.3% of its workTransplantation: 0 fractional works · 0.3% of its workObstetrics and Gynecology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.5% of its workHealth Professions: 2 fractional works · 3.1% of its workPharmacy: 1 fractional works · 1.2% of its workGeneral Health Professions: 1 fractional works · 0.9% of its workHealth Information Management: 0 fractional works · 0.4% of its workEmergency Medical Services: 0 fractional works · 0.3% of its workPhysical Therapy, Sports Therapy and Rehabilitation: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workVeterinary: 0 fractional works · 0.3% of its workSmall Animals: 0 fractional works · 0.3% of its workLife Sciences: 14 fractional works · 22.9% of its workBiochemistry, Genetics and Molecular Biology: 7 fractional works · 11.6% of its workMolecular Biology: 3 fractional works · 4.8% of its workGenetics: 2 fractional works · 3.9% of its workCancer Research: 1 fractional works · 2.2% of its workBiophysics: 0 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.1% of its workNeuroscience: 4 fractional works · 6.9% of its workCellular and Molecular Neuroscience: 2 fractional works · 2.4% of its workNeurology: 1 fractional works · 1.7% of its workCognitive Neuroscience: 1 fractional works · 1.4% of its workSensory Systems: 1 fractional works · 1.0% of its workBiological Psychiatry: 0 fractional works · 0.3% of its workImmunology and Microbiology: 2 fractional works · 3.4% of its workImmunology: 2 fractional works · 3.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.7% of its workPharmacology: 0 fractional works · 0.4% of its workToxicology: 0 fractional works · 0.3% of its workAgricultural and Biological Sciences: 0 fractional works · 0.3% of its workInsect Science: 0 fractional works · 0.3% of its workSocial Sciences: 4 fractional works · 6.6% of its workEconomics, Econometrics and Finance: 4 fractional works · 5.6% of its workEconomics and Econometrics: 4 fractional works · 5.6% of its workPsychology: 0 fractional works · 0.5% of its workExperimental and Cognitive Psychology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workSocial Sciences: 0 fractional works · 0.3% of its workBusiness, Management and Accounting: 0 fractional works · 0.2% of its workDecision Sciences: 0 fractional works · 0.1% of its workPhysical Sciences: 4 fractional works · 6.3% of its workMathematics: 2 fractional works · 3.3% of its workStatistics and Probability: 2 fractional works · 3.3% of its workComputer Science: 1 fractional works · 1.0% of its workComputational Theory and Mathematics: 0 fractional works · 0.7% of its workArtificial Intelligence: 0 fractional works · 0.3% of its workChemistry: 1 fractional works · 0.9% of its workOrganic Chemistry: 1 fractional works · 0.9% of its workEnvironmental Science: 0 fractional works · 0.6% of its workHealth, Toxicology and Mutagenesis: 0 fractional works · 0.6% of its workEngineering: 0 fractional works · 0.3% of its workMaterials Science: 0 fractional works · 0.2% of its workALL ITS WORKEli Lilly (UnitedKingdom)63fractional works, 2022-now
Life Sciences23%Physical Sciences6%Health Sciences64%Social Sciences7%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 19 fields, with their numbers
    1. Medicine3860.7%
    2. Health Professions23.1%
    3. Veterinary00.3%
    1. Biochemistry, Genetics and Molecular Biology711.6%
    2. Neuroscience46.9%
    3. Immunology and Microbiology23.4%
    4. Pharmacology, Toxicology and Pharmaceutics00.7%
    5. Agricultural and Biological Sciences00.3%
    1. Economics, Econometrics and Finance45.6%
    2. Psychology00.5%
    3. Social Sciences00.3%
    4. Business, Management and Accounting00.2%
    5. Decision Sciences00.1%
    1. Mathematics23.3%
    2. Computer Science11.0%
    3. Chemistry10.9%
    4. Environmental Science00.6%
    5. Engineering00.3%
    6. Materials Science00.2%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.07× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.18× its world share, 7 worksBiochemistry, Geneti…Immunology and Microbiology: 3.34× its world share, 2 worksImmunology and Micro…Neuroscience: 4.24× its world share, 4 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 1.94× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.60× its world share, 1 worksChemistryComputer Science: 0.13× its world share, 1 worksComputer ScienceEngineering: 0.02× its world share, 0 worksEngineeringEnvironmental Science: 0.11× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.06× its world share, 0 worksMaterials ScienceMathematics: 2.81× its world share, 2 worksMathematicsHealth Professions: 1.19× its world share, 2 worksHealth ProfessionsMedicine: 3.16× its world share, 38 worksMedicineVeterinary: 2.60× its world share, 0 worksVeterinaryBusiness, Management and Accounting: 0.06× its world share, 0 worksBusiness, Management…Decision Sciences: 0.09× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 2.61× its world share, 4 worksEconomics, Econometr…Psychology: 0.15× its world share, 0 worksPsychologySocial Sciences: 0.02× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Neuroscience, 4.2×. Every wedge is a field page.

All 19 fields, with their numbers
  1. Neuroscience4.24×4 works
  2. Immunology and Microbiology3.34×2 works
  3. Medicine3.16×38 works
  4. Mathematics2.81×2 works
  5. Economics, Econometrics and Finance2.61×4 works
  6. Veterinary2.60×0 works
  7. Biochemistry, Genetics and Molecular Biology2.18×7 works
  8. Pharmacology, Toxicology and Pharmaceutics1.94×0 works
  9. Health Professions1.19×2 works
  10. Chemistry0.60×1 works
  11. Psychology0.15×0 works
  12. Computer Science0.13×1 works
  13. Environmental Science0.11×0 works
  14. Decision Sciences0.09×0 works
  15. Agricultural and Biological Sciences0.07×0 works
  16. Materials Science0.06×0 works
  17. Business, Management and Accounting0.06×0 works
  18. Engineering0.02×0 works
  19. Social Sciences0.02×0 works

Who are the top researchers at Eli Lilly (United Kingdom)?

Ranked on the quality score, Zeshan Ahmed, Tracey K. Murray and Catherine C. Reed lead among researchers whose main affiliation is Eli Lilly (United Kingdom).

  1. 1 Zeshan Ahmed United Kingdom · #279,186 worldwide 7.1k citations · 109 works
  2. 2 Tracey K. Murray United Kingdom · #364,337 worldwide 7.4k citations · 121 works
  3. 3 Catherine C. Reed United Kingdom · #541,286 worldwide 4.7k citations · 159 works
  4. 4 Hugh M. Marston United Kingdom · #684,875 worldwide 4.9k citations · 100 works
  5. 5 Sarah J. Glover United Kingdom · #723,111 worldwide 1.6k citations · 19 works
  6. 6 Suchira Bose United Kingdom · #823,978 worldwide 3.2k citations · 65 works
  7. 7 Mark David Tricklebank United Kingdom · #850,099 worldwide 8k citations · 161 works
  8. 8 Adrian J. Mogg United Kingdom · #888,631 worldwide 2k citations · 34 works
  9. 9 Jacqueline Brown United Kingdom · #929,837 worldwide 2.2k citations · 75 works
  10. 10 Michael J. O’Neill United Kingdom · #930,017 worldwide 7.6k citations · 163 works
All ranked researchers at Eli Lilly (United Kingdom)

What are the most cited papers from Eli Lilly (United Kingdom)?

The most cited paper from Eli Lilly (United Kingdom) is "Biological insights from 108 schizophrenia-associated genetic loci" (Stephan Ripke et al., 2014), with 8,181 citations. Next come "Mapping genomic loci implicates genes and synaptic biology in schizophrenia" (2,894) and "International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors" (2,839).

Most cited papers
#PaperReleasedCitations
1 Biological insights from 108 schizophrenia-associated genetic loci Stephan Ripke et al. · Nature Open access297 authors Jul 2014 8,181
2 Mapping genomic loci implicates genes and synaptic biology in schizophrenia Vassily Vladimirovich Trubetskoy et al. · Nature Open access613 authors 8 Apr 2022 2,894
3 International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors A­llyn C. Howlett, F. Barth, T.I. Bonner et al. · Pharmacological Reviews Jun 2002 2,839
4 Definition and diagnostic criteria of clinical obesity Francesco Rubino et al. · The Lancet Diabetes & Endocrinology Open access 14 Jan 2025 1,660
5 Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects Christian R. Marshall et al. · Nature Genetics Open access263 authors 21 Nov 2016 1,160
All 60 most cited papers, with filters and sorting

Which keywords describe research at Eli Lilly (United Kingdom)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Neuroinflammation, Biomarkers, Glycemic Control, Diabetes, Insulin Therapy, Neurodegeneration, Alzheimer's Disease and Neurological Disorders.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Oxidative Stress4▲ 4.3×9 topics
  2. Neuroinflammation4▲ 24×5 topics
  3. Biomarkers4▲ 9.6×4 topics
  4. Epidemiology4▲ 1.69×21 topics
  5. Glycemic Control4▲ 39×4 topics
  6. Diabetes4▲ 11×6 topics
  7. Insulin Therapy4▲ 45×3 topics
  8. Neurodegeneration4▲ 18×6 topics
  9. Quality of Life4▲ 3.9×10 topics
  10. Alzheimer's Disease3▲ 20×6 topics
  11. Inflammation3▲ 2.5×18 topics
  12. Neurological Disorders3▲ 9.5×7 topics
  13. Breast Cancer3▲ 20×6 topics
  14. Aging3▲ 9.2×4 topics
  15. Obesity3▲ 6.2×9 topics
  16. Type 2 Diabetes3▲ 20×3 topics
  17. Amyloid Hypothesis3▲ 74×1 topic
  18. Genetics3▲ 6.3×9 topics
  19. Tau Pathology3▲ 74×1 topic
  20. Therapeutic Strategies3▲ 46×2 topics
  21. Inflammatory Bowel Disease3▲ 35×4 topics
  22. Clinical Trials2▲ 5.7×8 topics
  23. Cost-effectiveness Analysis2▲ 49×1 topic
  24. Health Utility Measures2▲ 49×1 topic
  25. Heart Failure2▲ 8.0×3 topics
  26. Neuroimaging2▲ 14×3 topics
  27. Cardiovascular Risk2▲ 11×6 topics
  28. Dementia2▲ 36×1 topic
  29. Mild Cognitive Impairment2▲ 40×1 topic
  30. Clinical Guidelines2▲ 11×2 topics
  31. Metastatic Breast Cancer2▲ 55×2 topics
  32. Cardiovascular Outcomes2▲ 52×1 topic
  33. Glucose Control2▲ 52×1 topic
  34. Headache Disorders2▲ 120×1 topic
  35. Migraine2▲ 70×1 topic
  36. Lifestyle Intervention2▲ 31×2 topics
  37. CDK4/6 Inhibitors2▲ 94×1 topic
  38. Palbociclib2▲ 94×1 topic
  39. Targeted Therapy2▲ 12×2 topics
  40. Immunology2▲ 24×2 topics

Which research topics does Eli Lilly (United Kingdom) publish most on?

By volume in 2022-now: Alzheimer's disease research and treatments, Health Systems, Economic Evaluations, Quality of Life, Dementia and Cognitive Impairment Research and Migraine and Headache Studies.

  1. 1 Alzheimer's disease research and treatments Physiology 3 works
  2. 2 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 2 works
  3. 3 Dementia and Cognitive Impairment Research Psychiatry and Mental health 2 works
  4. 4 Migraine and Headache Studies Psychiatry and Mental health 2 works
  5. 5 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 2 works
  6. 6 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 2 works
  7. 7 Statistical Methods in Clinical Trials Statistics and Probability 2 works
  8. 8 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 1 works
  9. 9 Inflammatory Bowel Disease Genetics 1 works
  10. 10 Psoriasis: Treatment and Pathogenesis Immunology 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available35.8%not open64.2%

World: 40% of research is openly available.

with international co-authors56.0%domestic only44.0%

World: 18% is written across borders.

How has Eli Lilly (United Kingdom)'s research output changed?

Output in 2022-2025 was 38% lower than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Eli Lilly (United Kingdom) as a percentage of every work published that year, 0.00019% in 2024.

still counting0.0010%0.0020%Eli Lilly (United Kingdom)0.00024% in 202519801990200020102020

Fractional works of Eli Lilly (United Kingdom) over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year, against all institutions in the same year.

10%20%all institutions10.0% in 2020Eli Lilly (United Kingdom)9.4% in 202020102020

Of each year's output, the share that reached the world's 10% most cited for its field and year. Peak 18.8% in 2018.

Other research institutions in Basingstoke

All research institutions in Basingstoke

Share Eli Lilly (United Kingdom)'s ranking

Eli Lilly (United Kingdom) on Science Explorer

A card with Eli Lilly (United Kingdom)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Eli Lilly (United Kingdom). Posts are plain text and can be reported.